NEW USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN

The present invention relates to methods and pharmaceutical compositions for treating heart failure in a pediatric human patient comprising administration to said patient of a therapeutically effective amount or a prophylactically effective amount of a combination of a therapeutic agent blocking the...

Full description

Saved in:
Bibliographic Details
Main Authors AYALASOMAYAJULA, Surya Prakash, BUSH, Christopher, TRUEBY, Bernd, CHEN, Fabian, WINZENBURG, Gesine, BERKHIN, Masha
Format Patent
LanguageEnglish
French
German
Published 12.12.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to methods and pharmaceutical compositions for treating heart failure in a pediatric human patient comprising administration to said patient of a therapeutically effective amount or a prophylactically effective amount of a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme, in particular of a combination of sacubitril and valsartan in a pharmaceutically acceptable form and in a 1:1 molar ratio.
Bibliography:Application Number: EP20170703477